Assessment of High-Risk Human Papillomavirus Infections Using Clinician- and Self-Collected Cervical Sampling Methods in Rural Women from Far Western Nepal

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

The Natural History of Cervical Human Papillomavirus Infections and Cervical Cancer

(2013) Cosette Marie Wheeler   OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA

High-Risk Human Papillomavirus Messenger RNA Testing in Physician- and Self-Collected Specimens for Cervical Lesion Detection in High-Risk Women, Kenya

(2013) Jie Ting et al.   SEXUALLY TRANSMITTED DISEASES

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (The FASE Study)

(2012) Joseph Monsonego et al.   GYNECOLOGIC ONCOLOGY

High-risk HPV testing on self-sampledversusclinician-collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening

(2012) Peter J.F. Snijders et al.   INTERNATIONAL JOURNAL OF CANCER

The APTIMA HPV assayversusthe hybrid capture 2 test in triage of women with ASC-US or LSIL cervical cytology: A meta-analysis of the diagnostic accuracy

(2012) Marc Arbyn et al.   INTERNATIONAL JOURNAL OF CANCER

High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: A population-based study

(2012) Shikha Srivastava et al.   JOURNAL OF BIOSCIENCES

Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method

(2012) F.-H. Zhao et al.   JNCI-Journal of the National Cancer Institute

Knowledge and Acceptability of Pap Smears, Self-Sampling and HPV Vaccination among Adult Women in Kenya

(2012) Anne F. Rositch et al.   PLoS One

Human Papillomavirus and Cancer Prevention: Gaps in Knowledge and Prospects for Research, Policy, and Advocacy

(2012) Eduardo L. Franco et al.   VACCINE

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

(2011) Eduardo Lazcano-Ponce et al.   LANCET

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Human papillomavirus infection in women with and without cervical cancer in Nepal

(2009) Ang Tshering Lama Sherpa et al.   CANCER CAUSES & CONTROL

Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review

(2008) Jennifer S. Smith et al.   JOURNAL OF ADOLESCENT HEALTH

A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination

(2008) Neerja Bhatla et al.   VACCINE